THE CORE INSTITUTE SPECIALTY HOSPITA — History
CCN 030108 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$91M
Latest Revenue (FY2022)
+22.0%
Revenue CAGR (3yr)
9.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $61M | $67M | $91M | +37.1% | +22.0% |
| Operating Expenses | $55M | $61M | $83M | +35.4% | +22.8% |
| Operating Margin | 10.4% | 8.0% | 9.2% | +14.1% | -5.9% |
| Net Income | $6M | $5M | $8M | +56.5% | +14.8% |
| Licensed Beds | 28 | 28 | 28 | +0.0% | +0.0% |
| Total Patient Days | 2,050 | 927 | 832 | -10.2% | -36.3% |
| Medicare Day % | 38% | 39% | 32% | -18.0% | -8.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +48.9% ($61M → $91M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+22.0%
This Hospital
+7.6%
State Avg
Latest Margin
9.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $106M | 8.6% |
| FY2024 (proj) | $121M | 8.0% |
| FY2025 (proj) | $136M | 7.4% |